Serial Number | 97276905 |
Word Mark | ARCHIMMUNE |
Filing Date | Monday, February 21, 2022 |
Status | 732 - THIRD EXTENSION - GRANTED |
Status Date | Tuesday, August 27, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, January 10, 2023 |
Goods and Services | Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, February 24, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Archimmune Therapeutics Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Lexington, MA 02421 |
Party Name | Archimmune Therapeutics Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Lexington, MA 02421 |
Event Date | Event Description |
Thursday, February 24, 2022 | NEW APPLICATION ENTERED |
Thursday, February 24, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, December 5, 2022 | ASSIGNED TO EXAMINER |
Monday, December 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, December 21, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, January 10, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, January 10, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, March 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Monday, October 9, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, October 10, 2023 | TEAS PETITION TO REVIVE RECEIVED |
Thursday, September 7, 2023 | SOU EXTENSION 1 FILED |
Tuesday, October 10, 2023 | PETITION TO REVIVE-GRANTED |
Tuesday, October 10, 2023 | NOTICE OF REVIVAL - E-MAILED |
Tuesday, October 10, 2023 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
Tuesday, October 10, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Wednesday, October 11, 2023 | NOTICE OF REVIVAL - E-MAILED |
Monday, October 23, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Thursday, October 26, 2023 | SOU EXTENSION 1 GRANTED |
Friday, October 27, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, February 5, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, February 5, 2024 | SOU EXTENSION 2 FILED |
Monday, February 5, 2024 | SOU EXTENSION 2 GRANTED |
Wednesday, February 7, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, August 27, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, August 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, August 27, 2024 | SOU EXTENSION 3 GRANTED |
Tuesday, August 27, 2024 | SOU EXTENSION 3 FILED |